The FLT3 inhibitor tandutinib (formerly MLN518) has sequence-independent synergistic effects with cytarabine and daunorubicin
- 15 August 2009
- journal article
- Published by Informa UK Limited in Cell Cycle
- Vol. 8 (16), 2621-2630
- https://doi.org/10.4161/cc.8.16.9355